UFP TECHNOLOGIES INC (UFPT)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for UFPT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| UFPT | Director | 73 | [] | ["AuditCommittee","CompensationCommittee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| STE | Retired, Former President & Founder Jetty Lane Associates | 73 | ["1","Retired certified public accountant with 27 years of experience in two large global accounting firms","Founder and President of Jetty Lane Associates","Life Sciences Business Development Officer for Palmer & Dodge, LLP","Partner with KPMG LLP, serving as Partner-in-Charge of National Medical Technologies Practice","Employee at Coopers & Lybrand, named Partner-in-Charge of its Life Sciences practice","Director of Hanger, Inc. from 2003 to 2018","Director of Frequency Therapeutics, Inc. from 2020 to 2023","Director of Alexandria Real Estate Equities, Inc. from 2022 to 2025","Director of UFP Technologies, Inc. since 2017"] | ["Audit","Compensation and Organization Development","Audit Committee","Nominating and Governance Committee (Chair)"] | 2026 |
| ARE | Prior Partner at KPMG LLP and Prior National Partner-in-Charge of the Life Sciences practice for Coopers & Lybrand (now PricewaterhouseCoopers LLP); Director | 71 | ["served as a director of STERIS PLC", "served as a director of UFP Technologies, Inc.", "served as a director of Falmouth Academy", "served as a director of Hanger, Inc.", "served as a director of Frequency Therapeutics, Inc.", "served as a director of Atrius Health", "Business Development Officer at Edwards Angell Palmer & Dodge LLP", "Partner at KPMG LLP", "National Partner-in-Charge of Life Sciences practice for Coopers & Lybrand", "founding board member of MassMEDIC", "retired CPA", "Masters Professional Director Certification from the American College of Corporate Directors", "knowledge and experience in accounting, finance, and capital markets", "public company experience in the medical device industry"] | ["chair of STERIS\u2019s nominating and governance committee", "member of its audit committee", "chair of UFP\u2019s audit committee", "member of its nominating committee"] | 2024 |
Biography sourced from the proxy statement filing.
The Board of Directors has determined that Ms. Feldmann is independent under applicable Nasdaq listing standards. Ms. Feldmann is a member of the Nominating Committee. Ms. Feldmann serves as Chair of the Audit Committee and is a member of the Audit Committee and meets the enhanced independence standards for audit committee members set forth in applicable SEC rules and Nasdaq listing standards. The Board of Directors has determined that Ms. Feldmann qualifies as an audit committee financial expert, as defined by applicable SEC rules.